Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH Treatment and Immune Function in Children with Short Stature
ChiCTR2500095743Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peg-somatropin in growth disorder (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Single cell sequencing. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
peg-somatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on ChiCTR2500095743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095743.